Shareholding for the Period Ended December 31, 2016
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here17-01-2017
17-01-2017
Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.29-12-2016
Intimation of publication of notice of postal ballot Notice
Bliss GVS Pharma Ltd has informed BSE regarding Intimation of publication of notice for dispatch of Postal Ballot Notice.05-12-2016
Notice of Postal Ballot
Bliss GVS Pharma Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.25-11-2016
Bliss GVS Healthcare Won a Three Year Contract worth USD 111.40 Million for provision of Medical Healthcare Services in Kenya
Bliss GVS Pharma Ltd has informed BSE regarding "Bliss GVS Healthcare Won a Three Year Contract worth USD 111.40 Million for provision of Medical Healthcare Services in Kenya".22-11-2016
Outcome of Board Meeting
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 26, 2016, has approved the following;1. The Board has pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, would like to inform that the Bliss GVS Healthcare Ltd, the Kenyan step down subsidiary of M/s Bliss GVS Pharma Ltd, has won an Annual Contract worth USD 38.76 Million (USD...27-10-2016
Standalone & Consolidated Financial Results, Limited Review Report for September 30, 2016
Bliss GVS Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Consolidated Financial Results for the period ended September 30, 20163. Standalone Limited Review for the period ended September 30, 20164. Consolidated Limited Review for the period ended September 30, 201627-10-2016
Shareholding for the Period Ended September 30, 2016
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here21-10-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Bliss GVS Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.19-10-2016